Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Fatty acid amide hydrolase (FAAH) inhibitor design and preclinical studies: lessons learned from BIA 10–2474 and the challenges ahead
AuthorsAlessia Catalano; Filomena Fezza; Andrea Duranti; Maria Maddalena Cavalluzzi; Giovanni Lentini; Giuseppe Felice Mangiatordi; Marco Bruno Luigi Rocchi; Mauro Maccarrone
Affiliations1. University of Bari Aldo Moro; 2. University of Rome “Tor Vergata”; 3. University of Urbino Carlo Bo; 4. National Research Council of Italy; 5. University of L’Aquila; 6. Santa Lucia IRCCS
A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)
AuthorsLuis Adrián De Jesús-González; Alan Orlando Santos-Mena; Carlos Noé Farfán-Morales; Moisés León-Juárez; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Daniel Cordero-Rivera; Selvin Noé Palacios-Rápalo; Flor Itzel Lira-Hernández; Rosa María Del Ángel
Affiliations1. Instituto Mexicano del Seguro Social; 2. Center for Research and Advanced Studies (CIN VESTAV-IPN); 3. Unidad Cuajimalpa; 4. Instituto Nacional de Perinatología “Isidro Espinosa de los Reyes”; 5. Instituto Mexicano del Seguro Social (IMSS); 6. Universidad Veracruzana (UV); 7. Universidad Autónoma de Sinaloa (UAS); 8. Instituto Politécnico Nacional (IPN); 9. Institut Pasteur, Université Paris Cité
Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications
AuthorsMichail Papadourakis; Evangelia Efraimia Amaxopoulou; Minos-Timotheos Matsoukas
Affiliations1. Cloudpharm PC; 2. University of West Attica
Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets
AuthorsJiahua Chen; Trent Quist; Ronabelle Fang; Henry Thanh Nguyen; Maria-Eirini Pandelia
Affiliations1. Brandeis University
Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?
AuthorsAndrea Hinas; Christian G. Riedel
Affiliations1. Stockholm University; 2. Karolinska Institute
An overview of the current animal models of Marburg virus disease for countermeasure development
AuthorsTakeshi Saito; Junki Maruyama; Ayato Takada
Affiliations1. The University of Texas Medical Branch; 2. Hokkaido University; 3. University of Zambia
Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities
AuthorsQianyi Chen; Hao Liu; Cien Sun; Ziming Wang; William C. Cho; Jianfei Shen
Affiliations1. Taizhou Hospital of Zhejiang Province Affiliated to Zhejiang University; 2. Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University; 3. Queen Elizabeth Hospital
Can Artificial intelligence meaningfully shorten drug discovery timelines? Current evidence, roadblocks and future directions
AuthorsJuan Luis Fernández-Martínez
Affiliations1. University of Oviedo
Advancing polypharmacology-based drug discovery using deep generative models
AuthorsJürgen Bajorath
Affiliations1. Lamarr Institute for Machine Learning and Artificial Intelligence, Rheinische Friedrich-Wilhelms-Universität
Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights
AuthorsHa-Yeon Song
Affiliations1. Korea Atomic Energy Research Institute (KAERI)
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
